SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-000307
Filing Date
2023-01-25
Accepted
2023-01-25 08:35:09
Documents
15
Period of Report
2023-01-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 36735
2 CERTIFICATE OF AMENDMENT phio_ex0301.htm EX-3.1 7901
3 PRESS RELEASE phio_ex9901.htm EX-99.1 14630
7 GRAPHIC image_001.jpg GRAPHIC 2342
  Complete submission text file 0001683168-23-000307.txt   247833

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20230124.xsd EX-101.SCH 3233
5 XBRL LABEL FILE phio-20230124_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE phio-20230124_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3727
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 23549904
SIC: 2834 Pharmaceutical Preparations